Table 1 Expert estimates from 44 NHS consultant oncologists compared with data from an observational study at a UK tertiary care oncology centre
From: Reply: Guesstimates are not good enough for determining what is happening in routine care
Parameter | Expert estimates | Observational study |
|---|---|---|
Duration of IrMdG chemotherapy | Mean duration 5.0 months | Mean duration 5.0 months (first line 5.2 months, second line 4.7 months) |
Incidence of febrile neutropenia (%) | 8.4 | 8.3 |
